In Case You Missed It
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Let's recognize that some moves are simply related to bonds, which are in the grips of a bizarre developed-world shortage.
There are nearly too many surging sectors to count.
Jim Cramer is opting for stocks like Allergan and Johnson & Johnson over Valeant Pharmaceuticals.
Johnson & Johnson (JNJ) plans to issue a transparency report annually going forward.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.